Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Nanomedicine Market Report Examines Products, Services and Growth Opportunities Through 2030

globenewswire.com
ABT Abbott Laboratories is mentioned as a company analyzed within the nanomedicine market report, which examines products, services, and growth opportunities. ARWR Arrowhead Pharmaceuticals Inc. is listed as a company being analyzed in the nanomedicine market report, focusing on its role in the industry. BMY Bristol Myers Squibb (formerly Celgene Corporation) is included in the nanomedicine market report's competitive assessment, indicating its involvement in the sector. GEHC GE Healthcare is mentioned as a company analyzed within the nanomedicine market report, highlighting its participation in the industry's growth. GILD Gilead Sciences Inc. is listed as a company whose products, services, and strategic initiatives are reviewed in the nanomedicine market report. INV Invitae Corporation (including CombiMatrix) is featured in the nanomedicine market report's competitive analysis, indicating its presence in the field. JNJ Johnson & Johnson Services Inc. is identified as a company whose nanomedicine-related activities are assessed in the market report. TMO Thermo Fisher Scientific Inc. (including Life Technologies) is analyzed in the nanomedicine market report for its products, services, and strategies. MRK Merck & Co. Inc. is analyzed in the nanomedicine market report, focusing on its role and strategies within the industry. NVS Novavax is listed as a company analyzed within the nanomedicine market report, indicating its involvement in the sector. PFE Pfizer Inc. is mentioned as a company whose nanomedicine activities are assessed in the market report, covering its products and strategies. TEVA Teva Pharmaceutical Industries Ltd is analyzed in the nanomedicine market report as part of the competitive landscape.

Nanomedicine Market Report Examines Products, Services and Growth Opportunities Through 2030 Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Nanomedicine Market by Nano-Type, Modality, and Applications 2026-2030" has been added to ResearchAndMarkets.com's offering.

Comprehensive industry analysis evaluates nanomedicine technologies, nanoparticles, competitive strategies, market drivers and commercialization challenges.

A new market research report provides an in-depth assessment of the global nanomedicine market, highlighting emerging products, services and strategic opportunities expected to influence industry development from 2026 through 2030. The report examines how advances in nanoscale materials, devices and engineering are supporting more precise approaches to disease diagnosis, treatment and prevention.

Nanomedicine continues to attract attention across the healthcare, pharmaceutical, biotechnology and medical device industries. Its capabilities support the development of targeted drug delivery systems, advanced diagnostic tools, imaging agents and therapeutic platforms designed to interact with biological systems at molecular and cellular levels. These applications have the potential to improve treatment precision, enhance therapeutic efficiency and support better patient outcomes.

The nanomedicine market report analyzes nanoparticles used in medical applications, along with related products and services. It evaluates the role of nanoscale materials with specialized physical, chemical and biological properties that can be engineered for healthcare applications. The research also considers how continued innovation in nanotechnology may contribute to new clinical and commercial opportunities across multiple areas of medicine.

In addition to reviewing current and emerging nanomedicine applications, the report assesses key market factors shaping industry growth. These include technological advances, research and development activity, evolving healthcare requirements, product commercialization, investment priorities and demand for more targeted diagnostic and therapeutic solutions. The analysis identifies potential application areas while examining the opportunities available to market participants throughout the forecast period.

The report also addresses challenges that may affect the development and adoption of nanomedicine-based products and services. Key considerations include complex product development requirements, manufacturing scalability, clinical validation, regulatory pathways and the transition of promising research into commercially viable healthcare solutions. Understanding these factors is essential for organizations seeking to evaluate market potential, manage risk and develop effective long-term strategies.

A detailed competitive assessment reviews the products, services and strategic initiatives of leading nanomedicine companies. The report considers how industry participants are advancing their technology portfolios, pursuing innovation and positioning themselves within a rapidly evolving market. This analysis is designed to help stakeholders identify competitive trends, assess business strategies and better understand the factors influencing market leadership.

The study combines qualitative insights with quantitative market analysis to deliver a balanced view of the nanomedicine industry. Market forecasts covering 2026 through 2030 provide perspective on expected development, potential demand and future commercial opportunities. The findings can support strategic planning, investment evaluation, product development and market entry decisions.

The nanomedicine market report is relevant to pharmaceutical and biotechnology companies, healthcare organizations, medical technology developers, research institutions, investors and other stakeholders monitoring innovation in advanced medicine. By bringing together market forecasts, application analysis, competitive intelligence and an assessment of industry challenges, the report offers a comprehensive resource for evaluating the future direction of nanomedicine products and services.

As nanoscale technologies continue to progress, nanomedicine is expected to remain an important area of healthcare research and commercialization. The report provides actionable market intelligence for organizations seeking to understand emerging opportunities and make informed decisions in the global nanomedicine market through 2030.

Key Topics Covered:

1. Executive Summary

2. Introduction

2.1 Defining Nanomedicine

2.2 Nanomedicine Market Drivers

2.3 Nanomedicine Market Challenges

2.4 Pandemic Impact Analysis

2.5 Nanomedicine Regulatory Analysis

2.6 Nanomedicine Value Chain Analysis

3. Nanomedicine Technology and Application Analysis

3.1 Nanomedicine Indication Analysis

3.1.1 Clinical Oncology

3.1.2 Infectious Diseases

3.1.3 Cardiovascular Diseases

3.1.4 Orthopaedic Diseases

3.1.5 Neurological Diseases

3.1.6 Urological Diseases

3.1.7 Ophthalmological Diseases

3.1.8 Immunological Diseases

3.2 Nanomedicine Application Analysis

3.2.1 Drug Delivery

3.2.2 Therapeutics

3.2.3 Diagnostic Imaging (In-Vitro & In-Vivo)

3.2.4 Anti-inflammatories

3.2.5 Anti-invectives & Vaccines

3.2.6 Regenerative Medicine

3.2.7 Implants

3.3 Nanomedicine Molecule Analysis

3.3.1 Nanoparticles

3.3.1.1 Metal & Metal Oxide Nanoparticles

3.3.1.2 Liposomes

3.3.1.3 Polymers & Polymer Drug Conjugates

3.3.1.4 Hydrogel Nanoparticles

3.3.1.5 Dendrimers

3.3.1.6 Inorganic Nanoparticles

3.3.2 Nanoshells

3.3.3 Nanotubes

3.3.4 Nanodevices

3.4 Regional Adoption of Nanomedicine

4. Nanorobotics

4.1 Nanorobotics Solutions and Applications

4.2 The Commercial Environment for Nanorobotics

5. Nanomedicine Company Analysis

5.1 Abbott Laboratories

5.2 Arrowhead Pharmaceuticals Inc.

5.3 Celgene Corporation (Bristol Myers Squibb)

5.4 DiaSorin S.p.A.

5.5 GE Healthcare

5.6 Gilead Sciences Inc.

5.7 Invitae Corporation (CombiMatrix)

5.8 Johnson & Johnson Services Inc.

5.9 Leadient BioSciences Inc.

5.10 Thermo Fisher Scientific Inc. (Life Technologies)

5.11 Luminex Corporation (DiaSorin Company)

5.12 MagArray Inc.

5.13 Mallinckrodt Pharmaceuticals

5.14 Merck & Co. Inc.

5.15 Nanospectra Biosciences

5.16 Novsvax

5.17 Pfizer Inc.

5.18 Sanofi SA

5.19 Teva Pharmaceutical Industries Ltd

5.20 UCB S.A.

6. Nanomedicine Market Analysis and Forecasts 2026-2030

6.1 Global Nanomedicine Market 2026-2030

6.1.1 Global Nanomedicine Market by Modality

6.1.2 Global Nanomedicine Market by Application

6.1.3 Global Nanomedicine Market by Indication

6.1.4 Global Nanomedicine Market by Molecule Type

6.1.4.1 Global Nanomedicine Molecule Market by Nanoparticles Type

6.1.5 Global Nanomedicine Market by Region

6.1.5.1 North America Nanomedicine Market by Country

6.1.5.2 Europe Nanomedicine Market by Country

6.1.5.3 APAC Nanomedicine Market by Country

6.1.5.4 MEA Nanomedicine Market by Country

6.1.5.5 Latin America Nanomedicine Market by Country

6.2 Regional Nanomedicine Market 2026-2030

6.2.1 North America Nanomedicine Market: Application, Indication and Molecule

6.2.2 Europe Nanomedicine Market: Application, Indication, and Molecule

6.2.3 APAC Nanomedicine Market: Application, Indication, and Molecule

6.2.4 MEA Nanomedicine Market: Application, Indication, and Molecule

6.2.5 Latin America Nanomedicine Market: Application, Indication, and Molecule

6.3 Additional Nanomedicine Market Factors to Consider

7. Conclusions and Recommendations

List of Figures

Figure 1: Nanomedicine Structure

Figure 2: Nanoparticle Structure

Figure 3: Nanoshell Structure

Figure 4: Multi-walled Carbon Nanotube

Figure 5: Nanodevice Structure

Figure 6: Global Nanomedicine Market 2026-2030

Figure 7: Global Nanomedicine Market by Modality 2026-2030

Figure 8: Global Nanomedicine Market by Application 2026-2030

Figure 9: Global Nanomedicine Market by Indication 2026-2030

Figure 10: Global Nanomedicine Market by Molecule Type 2026-2030

Figure 11: Global Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Figure 12: Global Nanomedicine Market by Region 2026-2030

Figure 13: North America Nanomedicine Market by Country 2026-2030

Figure 14: Europe Nanomedicine Market by Country 2026-2030

Figure 15: APAC Nanomedicine Market by Country 2026-2030

Figure 16: MEA Nanomedicine Market by Country 2026-2030

Figure 17: Latin America Nanomedicine Market by Country 2026-2030

Figure 18: North America Nanomedicine Market by Modality 2026-2030

Figure 19: North America Nanomedicine Market by Application 2026-2030

Figure 20: North America Nanomedicine Market by Indication 2026-2030

Figure 21: North America Nanomedicine Market by Molecule Type 2026-2030

Figure 22: North America Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Figure 23: Europe Nanomedicine Market by Modality 2026-2030

Figure 24: Europe Nanomedicine Market by Application 2026-2030

Figure 25: Europe Nanomedicine Market by Indication 2026-2030

Figure 26: Europe Nanomedicine Market by Molecule Type 2026-2030

Figure 27: Europe Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Figure 28: APAC Nanomedicine Market by Modality 2026-2030

Figure 29: APAC Nanomedicine Market by Application 2026-2030

Figure 30: APAC Nanomedicine Market by Indication 2026-2030

Figure 31: APAC Nanomedicine Market by Molecule Type 2026-2030

Figure 32: APAC Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Figure 33: MEA Nanomedicine Market by Modality 2026-2030

Figure 34: MEA Nanomedicine Market by Application 2026-2030

Figure 35: MEA Nanomedicine Market by Indication 2026-2030

Figure 36: MEA Nanomedicine Market by Molecule Type 2026-2030

Figure 37: MEA Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Figure 38: Latin America Nanomedicine Market by Modality 2026-2030

Figure 39: Latin America Nanomedicine Market by Application 2026-2030

Figure 40: Latin America Nanomedicine Market by Indication 2026-2030

Figure 41: Latin America Nanomedicine Market by Molecule Type 2026-2030

Figure 42: Latin America Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

List of Tables

Table 1: Global Nanomedicine Market 2026-2030

Table 2: Global Nanomedicine Market by Modality 2026-2030

Table 3: Global Nanomedicine Market by Application 2026-2030

Table 4: Global Nanomedicine Market by Indication 2026-2030

Table 5: Global Nanomedicine Market by Molecule Type 2026-2030

Table 6: Global Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Table 7: Global Nanomedicine Market by Region 2026-2030

Table 8: North America Nanomedicine Market by Country 2026-2030

Table 9: Europe Nanomedicine Market by Country 2026-2030

Table 10: APAC Nanomedicine Market by Country 2026-2030

Table 11: MEA Nanomedicine Market by Country 2026-2030

Table 12: Latin America Nanomedicine Market by Country 2026-2030

Table 13: North America Nanomedicine Market by Modality 2026-2030

Table 14: North America Nanomedicine Market by Application 2026-2030

Table 15: North America Nanomedicine Market by Indication 2026-2030

Table 16: North America Nanomedicine Market by Molecule Type 2026-2030

Table 17: North America Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Table 18: Europe Nanomedicine Market by Modality 2026-2030

Table 19: Europe Nanomedicine Market by Application 2026-2030

Table 20: Europe Nanomedicine Market by Indication 2026-2030

Table 21: Europe Nanomedicine Market by Molecule Type 2026-2030

Table 22: Europe Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Table 23: APAC Nanomedicine Market by Modality 2026-2030

Table 24: APAC Nanomedicine Market by Application 2026-2030

Table 25: APAC Nanomedicine Market by Indication 2026-2030

Table 26: APAC Nanomedicine Market by Molecule Type 2026-2030

Table 27: APAC Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Table 28: MEA Nanomedicine Market by Modality 2026-2030

Table 29: MEA Nanomedicine Market by Application 2026-2030

Table 30: MEA Nanomedicine Market by Indication 2026-2030

Table 31: MEA Nanomedicine Market by Molecule Type 2026-2030

Table 32: MEA Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Table 33: Latin America Nanomedicine Market by Modality 2026-2030

Table 34: Latin America Nanomedicine Market by Application 2026-2030

Table 35: Latin America Nanomedicine Market by Indication 2026-2030

Table 36: Latin America Nanomedicine Market by Molecule Type 2026-2030

Table 37: Latin America Nanomedicine Molecule Market by Nanoparticles Type 2026-2030

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/2v7gby

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.